• No results found

Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D

N/A
N/A
Protected

Academic year: 2020

Share "Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 compositions of blank sneDDs formulations varying in oil content
Table 2 solubility results of cyclovirobuxine D in various excipients (mean ± sD; n=3)
Table 4 Emulsification abilities of various cosurfactants
Figure 2 effect of oil content and cyclovirobuxine D loading on globule size.Notes: (A) *P0.05, **P0.01 vs 10% oil; (B) *P0.05, **P0.01 vs 1% cyclovirobuxine D.
+3

References

Related documents

An entry-index-thread course is a navigation course from an entry page via a sequence of index pages (thru index Malicious Web URLs and index web page-flipping Malicious

assistance with this investigation: Dr Ruthann Giusti, Epidemic Intelligence Service Officer from the Centers for Disease Control; the Immunization Program staff of the Illinois

Leadership Forums (Dugan & Komives, 2007; Eich, 2008; Zimmerman-Oster & Burkhardt, 1999): These development opportunities were designed to expose ELDP members to different

Figure 1.10 Synthesis of metal silicide NWs using chemical vapour deposition (CVD) of single source precursors (SSP). Each SSP pyrolyzes to deliver metal silicide material to..

In this paper, we propose the Advanced Generative Adversarial Networks (AGAN) to efficiently correct these issues; 1) we design a Laplacian pyramid framework as

To assess this, we tested whether the uptake of protein (Alexa-647 conjugated BSA) and apoptotic Jurkat cells could be increased in the presence of SP-D and/or GM-CSF (Figure 3)..

Ehlers-Danlos syndrome type IV, the vascular type of Ehlers-Danlos syndromes (EDS), is an inherited connective tissue disorder defined by characteristic facial features (acrogeria)